REGN4336
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for REGN4336, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer [Phase 1, Phase 2]